Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
1(9%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
2
18%
Ph phase_3
6
55%
Ph not_applicable
1
9%
Ph phase_1
1
9%
Ph phase_2
1
9%

Phase Distribution

1

Early Stage

1

Mid Stage

8

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
Phase 2Efficacy & side effects
1(9.1%)
Phase 3Large-scale testing
6(54.5%)
Phase 4Post-market surveillance
2(18.2%)
N/ANon-phased studies
1(9.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(9)
Other(1)

Detailed Status

Completed9
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (9.1%)
Phase 21 (9.1%)
Phase 36 (54.5%)
Phase 42 (18.2%)
N/A1 (9.1%)

Trials by Status

unknown19%
recruiting19%
completed982%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DRUG
Total Trials
11